Because multidrug resistance of these bacterial pathogens is of particular concern, the intraenous use of polymyxins reemerged worldwide (3).

• 因为特别考虑到这些细菌性病原体的多向性耐药，全世界都在重新开始静脉使用多粘菌素类药物。